Medical Devices DECODED
Previous edition: 09 May 2024
Share article
Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now
Register Now
Now Software Inc has extended it time and contact management software, Now Up-to-date, to run under Windows. The Portland, Oregon-based company said the move would expand its corporate customer base. Now Software sells mainly to large corporates that use a mixed environment of Macintosh and Windows personal computers and therefore need software than will run under both operating systems. Now Up-to-Date includes QuickAccess Manager, a permanent on-screen toolbar that gives users access to schedules, name and numbers, and additional diary dates that when entered in the QuickPad automatically appear under the appropriate date. The company said that its main rival was Microsoft Corp's Schedule Plus, which is given away with Microsoft Office. Now said that it had the edge over Schedule Plus because Now Up-to-date ran under more operating systems. It claims to be compatible with Macintosh, Windows 3.1 and Windows95. Now said it is currently working on expanding its software so it can be accessed by remote users with Personal Digital Assistants and pagers. It is also looking at making the software available on corporate Web servers so that companies can offer this information as part of their Web sites. The single-user version costs #100 and will be available this week. The workgroup edition for five users will costs #475, a 10-user version will costs #875 and a 50-user version will cost #3,900. Workgroup editions will be shipping next month.
Latest news
15th Annual Outsourcing in Clinical Trials East Coast 2024
The upcoming Outsourcing in Clinical Trials Europe 2024 conference will explore advancements in the clinical trial industry.
FDA issues warning on Getinge device amid quality concerns
Following a series of voluntary recalls, the FDA has urged healthcare providers to avoid Getinge’s intra-aortic balloon pumps over safety concerns.
4C Medical's AltaValve gains dual breakthrough designations from FDA
The device has received the designation for treating mitral regurgitation and mitral annular calcification.
UK report warns that economic instability is threatening life sciences sector
The report published by the Medicines Discovery Catapult warns that a mix of economic uncertainty and lack of facility access is pushing investors away from Britain’s healthcare SMEs.
Biosense introduces CARTO 3 System Version 8
The latest version features new modules, including the CARTO ELEVATE Module and CARTOSOUND FAM Module.
Qiagen and FBI partner on DNA quant digital PCR assays
The collaboration aims to develop a first-of-its-kind digital PCR assay capable of detecting and quantifying minimal amounts of DNA with high accuracy.
Vivalink introduces new solution for MCT and Holter monitoring
The new technology combines RPM technologies with advanced arrhythmia detection algorithms.
iHealth's COVID-19/Flu rapid test secures FDA EUA
Intended for over-the-counter use, the 3-in-1 test is intended for detecting Covid-19 and influenzas A and B.
Biotechs must prioritise ethics to deter GenAI “bad actors”
At the London Biotechnology Show, Microsoft’s senior director of life sciences discussed the ethical use of GenAI.
Leica Microsystems adds Viventis Microscopy to portfolio
The addition of Viventis adds light sheet technology to Leica’s line of research microscopes.
In our previous edition
Medical Devices Decoded
Samsung to acquire foetal ultrasound AI software company Sonio
08 May 2024
Medical Devices Decoded
Medtronic's renal denervation system receives approval in China
07 May 2024
Medical Devices Decoded
Angle signs AstraZeneca deal to develop prostate cancer assay
06 May 2024
Newsletters in other sectors
Aerospace, Defence & Security
Medical Devices
Travel and Tourism
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer